Identification of T-cell epitopes in clotting factor IX and lack of tolerance in inbred mice

被引:18
作者
Greenwood, R
Wang, B
Midkiff, K
White, GC
Lin, HF
Frelinger, JA
机构
[1] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA
关键词
factor IX; T-cell epitope;
D O I
10.1046/j.1538-7836.2003.00001.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immune responses to the factor IX protein pose problems for hemophilia B patients who develop antibodies against factor IX and for potential future treatment with gene therapy. To better define the response to human factor IX, we analyzed T-cell responses to human factor IX in factor IX knockout mice on BALB/c and C57BL/6 (136) backgrounds, both strains having CD4+ T cells that proliferate in response to human factor IX. Surprisingly, wild-type mice have similar factor IX-recognizing CD4+ T cells. We defined a dominant CD4+ epitope for each strain (CVETGVKITVVAGEH for BALB/c and LLELDEPLVLNSYVTPIC for 136) that was recognized by both factor IX knockout and wild-type mice. While human factor IX did not cross-react with the mouse homologs of these epitopes, immunization with peptides from murine factor IX stimulated proliferation in factor IX knockout mice and wild-type mice, demonstrating a failure to delete murine factor IX-specific T cells in normal mice.
引用
收藏
页码:95 / 102
页数:8
相关论文
共 19 条
[1]  
BRACKMANN HH, 1977, LANCET, V2, P933
[2]   ISOLATION OF MYELIN BASIC PROTEIN-REACTIVE T-CELL LINES FROM NORMAL HUMAN-BLOOD [J].
BURNS, J ;
ROSENZWEIG, A ;
ZWEIMAN, B ;
LISAK, RP .
CELLULAR IMMUNOLOGY, 1983, 81 (02) :435-440
[3]   Induction of TH1 and TH2 CD4+ T cell responses: The alternative approaches [J].
Constant, SL ;
Bottomly, K .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :297-322
[4]  
DiMichele DM, 2002, THROMB HAEMOSTASIS, V87, P52
[5]   Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX [J].
Fields, PA ;
Kowalczyk, DW ;
Arruda, VR ;
Armstrong, E ;
McCleland, ML ;
Hagstrom, JN ;
Pasi, KJ ;
Ertl, HCJ ;
Herzog, RW ;
High, KA .
MOLECULAR THERAPY, 2000, 1 (03) :225-235
[6]   Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9 [J].
Fields, PA ;
Arruda, VR ;
Armstrong, E ;
Chu, K ;
Mingozzi, F ;
Hagstrom, JN ;
Herzog, RW ;
High, KA .
MOLECULAR THERAPY, 2001, 4 (03) :201-210
[7]   Haemophilia B: database of point mutations and short additions and deletions - eighth edition [J].
Giannelli, F ;
Green, PM ;
Sommer, SS ;
Poon, MC ;
Ludwig, M ;
Schwaab, A ;
Reitsma, PH ;
Goossens, M ;
Yoshioka, A ;
Figueiredo, MS ;
Brownlee, GG .
NUCLEIC ACIDS RESEARCH, 1998, 26 (01) :265-268
[8]   Systemic antigen in the treatment of T-cell-mediated autoimmune diseases [J].
Liblau, R ;
Tisch, R ;
Bercovici, N ;
McDevitt, HO .
IMMUNOLOGY TODAY, 1997, 18 (12) :599-604
[9]   A coagulation factor IX-deficient mouse model for human hemophilia B [J].
Lin, HF ;
Maeda, N ;
Smithies, O ;
Straight, DL ;
Stafford, DW .
BLOOD, 1997, 90 (10) :3962-3966
[10]   IGG SUBCLASS IDENTIFICATION OF INHIBITORS TO FACTOR-IX IN HAEMOPHILIA-B PATIENTS [J].
ORSTAVIK, KH ;
MILLER, CH .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 68 (04) :451-454